UK markets open in 36 minutes

Titan Pharmaceuticals, Inc. (TTNP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
6.68+0.22 (+3.34%)
At close: 04:00PM EDT
6.35 -0.33 (-4.88%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.46
Bid0.00 x 0
Ask0.00 x 0
Day's range6.68 - 6.68
52-week range5.00 - 16.60
Avg. volume6,816
Market cap6.103M
Beta (5Y monthly)1.33
PE ratio (TTM)N/A
EPS (TTM)-7.41
Earnings date15 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

    SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that by letter dated January 24, 2024, the Company was notified by The Nasdaq Stock Market LLC that the Company has regained compliance with the minimum $1.00 bid price requirement and otherwise satisfies all applicable criteria for continued listing on The Nasdaq Capital Market. As such, the listing matter has been closed. About Titan Pharmaceutica

  • GlobeNewswire

    Titan Pharmaceuticals Announces Reverse Stock Split and Ratio

    SOUTH SAN FRANCISCO, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company's common stock, which will be effective following the filing of an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Amendment”). The Company's stockholders approved the reverse stock split at a Special Meeting of Stockholders on D

  • GlobeNewswire

    Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors

    SAN FRANCISCO, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") is pleased to announce the appointments of Dato’ Seow Gim Shen and Brynner Chiam to the Company’s Board of Directors, effective October 12, 2023. Mr. Shen has also been appointed Chairman of the Board. Simultaneous with the election of Mr. Shen and Mr. Chiam to the Board, David E. Lazar and Peter L. Chasey each submitted their resignations from the Board, effective immediately.